Preliminary observations on the pharmacokinetics of CDRI compound 81/470 in calves

被引：0
|
作者：
N.V. Nagaraja
S.K. Singh
G.K. Jain
S. Singh
R.C. Gupta
机构：
[1] Central Drug Research Institute,Pharmacokinetics and Metabolism Division
来源：
Veterinary Research Communications | 1998年 / 22卷
关键词：
anthelmintic; benzimidazole; calf; pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：67 / 72
页数：5
相关论文
共 35 条
  • [31] PRELIMINARY-OBSERVATIONS ON A NEW TRAIT, OPPOSITE 1ST COMPOUND LEAF, IN GLYCINE-MAX, (SOYBEAN)
    EVANS, DA
    PADDOCK, EF
    [J]. OHIO JOURNAL OF SCIENCE, 1980, 80 (03) : 122 - 125
  • [32] PRELIMINARY-OBSERVATIONS OF INTRAPERITONEAL CARBOPLATIN PHARMACOKINETICS DURING A PHASE-I STUDY OF THE NORTHERN-CALIFORNIA-ONCOLOGY-GROUP
    DEGREGORIO, MW
    LUM, BL
    HOLLERAN, WM
    WILBUR, BJ
    SIKIC, BI
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 18 (03) : 235 - 238
  • [33] SOME PRELIMINARY OBSERVATIONS CONCERNING EFFECT OF SILO FODDER AND HAY ON EARLY MORPHOLOGICAL DEVELOPMENT OF GASTRIC LINING AND METABOLIC FUNCTIONING OF RUMEN IN PRERUMINANT CALVES
    CANDAU, M
    [J]. COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES SERIE D, 1969, 268 (13): : 1823 - &
  • [34] Pharmacokinetics, Pharmacodynamics and Preliminary Observations for Clinical Activity and Safety of Multiple Doses of Human Mouse Chimeric Anti-CD22 Monoclonal Antibody (SM03) in Chinese Patients with Systemic Lupus Erythematosus
    Qian Zhao
    Xia Chen
    Jing Li
    Ji Jiang
    Mengtao Li
    Wen Zhong
    Zhengdong Li
    Shui-on Leung
    Fengchun Zhang
    Pei Hu
    [J]. Clinical Drug Investigation, 2016, 36 : 889 - 902
  • [35] Pharmacokinetics, Pharmacodynamics and Preliminary Observations for Clinical Activity and Safety of Multiple Doses of Human Mouse Chimeric Anti-CD22 Monoclonal Antibody (SM03) in Chinese Patients with Systemic Lupus Erythematosus
    Zhao, Qian
    Chen, Xia
    Li, Jing
    Jiang, Ji
    Li, Mengtao
    Zhong, Wen
    Li, Zhengdong
    Leung, Shui-on
    Zhang, Fengchun
    Hu, Pei
    [J]. CLINICAL DRUG INVESTIGATION, 2016, 36 (11) : 889 - 902
1234